MWI Veterinary Supply Inc. has settled federal allegations with the U.S. Attorney’s Office for Southern West Virginia regarding the improper tracking and distribution of controlled substance shipments to a Putnam County veterinarian, according to court records and federal officials.
Federal Allegations and Suspicious Order Monitoring Failures
U.S. Attorneys alleged that MWI Veterinary Supply Inc. failed to adequately flag large orders of oxycodone HCL and hydrocodone/acetaminophen placed by Dr. Clara Ann Mason between 2018 and 2023. According to federal officials, the volume of these orders exceeded normal medical or veterinary practices, raising concerns that the prescription painkillers could be diverted to illicit markets.
Federal investigators revealed that Mason’s high-volume purchases triggered a review by MWI’s Suspicious Order Monitoring System in September 2022. However, the system dismissed the alerts the very next day. Following that review, MWI filled nine additional orders for Mason without questioning the purchases, including a single order for 1,300 pills.
Did you know? Under the Controlled Substances Act, wholesale distributors like MWI are legally required to operate stringent monitoring systems to report suspicious orders and prevent the diversion of high-risk medications into communities.
Legal Stakes and Prior Judgments Against Dr. Mason
The regulatory scrutiny extends beyond the distributor. Last year, U.S. Attorneys secured a default judgment of $956,709 against Dr. Clara Ann Mason. U.S. District Judge Robert Chambers ordered Mason to pay maximum civil penalties after finding she not only acquired excessive quantities of drugs but also failed to properly secure or track them.
According to federal prosecutors, Mason attempted to conceal her activities by fabricating records. These compounding violations formed the foundation for both the civil penalties against the practitioner and the subsequent enforcement action against the supply chain distributor.
Official Responses and Regulatory Enforcement
U.S. Attorney for Southern West Virginia Moore Capito commended the investigation, emphasizing the strict legal obligations placed on pharmaceutical distributors. “The authority to distribute controlled substance requires complete adherence to the law and mandated internal policies to protect our communities against the consequences of diversion and abuse,” Capito stated regarding the settlement.
Jim Scott, Special Agent in Charge of the DEA’s Louisville Division, echoed those sentiments. Scott noted that registrants who fail to uphold reporting requirements under the Controlled Substances Act directly endanger local communities, expressing hope that the settlement serves as a costly reminder for MWI to take drug diversion threats seriously.
Frequently Asked Questions
What products does MWI Veterinary Supply distribute?
MWI distributes supplies and pharmaceuticals for the veterinary industry across the globe.
What specific drugs were ordered in excessive amounts?
According to federal officials, the orders involved hydrocodone/acetaminophen and oxycodone HCL.
Which federal agencies investigated the case?
The investigation involved the Drug Enforcement Administration (DEA) alongside the U.S. Attorney’s Office for Southern West Virginia.
Stay Informed on Regulatory Compliance
Subscribe to our newsletter to receive real-time updates on federal investigations, healthcare fraud enforcement, and pharmaceutical supply chain security.
Keep reading